Interestingly, CD133 reportedly regulates the expression of NANOG and OCT4, suggesting that CD133 inhibition induces the GMI-mediated reduction in NANOG and OCT4.10 Regardless of the regulation on CD133, inhibition of NANOG and OCT4 suggested the potential of GMI in restraining cancer stem cells. Here, NANOG is linked to cancer.